Related Experiment Video

Updated: Aug 23, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

Type 2 diabetes mellitus in the pediatric population

Allyson S Gaylor1, Michelle E Condren

  • 1Department of Pharmacy Practice, Texas Tech University Health Sciences Center, School of Pharmacy, Lubbock, Texas 79430, USA. allyson.gaylor@ttuhsc.edu

Pharmacotherapy
|August 12, 2004
PubMed

Insights

Type 2 diabetes is rising in children, with obesity and inactivity as key factors. More research and education are crucial for managing this pediatric health issue.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Disorders
  • Public Health

Background:

  • Type 2 diabetes mellitus (T2DM) is increasingly diagnosed in children, a shift from its traditional adult prevalence.
  • Factors contributing to pediatric T2DM include rising obesity rates and sedentary lifestyles.
  • Challenges exist in differentiating T2DM from Type 1 diabetes in children due to overlapping clinical presentations.

Purpose of the Study:

  • To review the current understanding of T2DM in pediatric populations.
  • To highlight the unique risk factors, presentation, and treatment considerations for children with T2DM.
  • To emphasize the need for further research and public health initiatives focused on pediatric T2DM.

Main Methods:

  • Literature review of pediatric T2DM prevalence, risk factors, and treatment.
  • Analysis of diagnostic challenges between T1DM and T2DM in children.
  • Examination of current therapeutic guidelines and research trends.

Main Results:

  • Pediatric T2DM is strongly associated with overweight/obesity, family history, and insulin resistance conditions like puberty.
  • Metformin is the sole FDA-approved medication for pediatric T2DM, with other agents under investigation.
  • Clinical differentiation between T1DM and T2DM in children can be difficult.

Conclusions:

  • Urgent need for increased awareness and education among healthcare professionals and the public regarding pediatric T2DM.
  • Further research is essential to understand the long-term course and optimal management of T2DM in children.
  • Preventive strategies targeting obesity and inactivity are critical for combating the rise of T2DM in pediatric populations.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.